Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06467708 · ClinicalTrials.gov registry record · NA
Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury
A NA study of TBI (Traumatic Brain Injury), sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT06467708: Recruiting NA study of TBI (Traumatic Brain Injury), sponsored by University of Texas Southwestern Medical Center.
NCT06467708 is a NA study of TBI (Traumatic Brain Injury) that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 42 participants, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06467708, a NA study of TBI (Traumatic Brain Injury), is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this pilot study is to assess the feasibility and safety of transcutaneous auricular neurostimulation (tan) in ICU patients with TBi and to determine the effect of tan on serum markers of inflammation. exploratory analyses will examine effects on such physiological parameters as blood pressure, heart rate, and intracranial pressure (iCP), as well as measures of neurological function.
Primary Outcome
Registered nurses providing direct care to ICU patients receiving tAN will be asked to complete the Sparrow Ascent ICU User Acceptance Questionnaire to assess the compatibility of tAN with patient care.
Conditions Studied
Interventions
- DEVICE Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2027-02-11 |
| Phase | NA |
What NCT06467708 shows while recruiting
NCT06467708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (75% lower).
The record links to 1 condition, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 1 intervention - of which Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN) is the first listed.
NCT06467708 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06467708 about?
NCT06467708 is a clinical study titled "Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury". The overarching goal of this pilot study is to assess the feasibility and safety of transcutaneous auricular neurostimulation (tan) in ICU patients with TBi and to determine the effect of tan on serum markers of inflammation. exploratory analyses will examine effects on such physiological parameters...
What is the current status of trial NCT06467708?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2025-02-11. Estimated completion is 2027-02-11.
What conditions does trial NCT06467708 study?
This clinical trial studies the following conditions: TBI (Traumatic Brain Injury).
What interventions are being tested in trial NCT06467708?
The interventions under investigation include: Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN) (DEVICE).
Who is sponsoring clinical trial NCT06467708?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06467708 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for TBI (Traumatic Brain Injury)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06467708's enrollment target sits among peer trials
42 15th of 20 higher than 5 of 20 other TBI (Traumatic Brain Injury) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other TBI (Traumatic Brain Injury) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
RECRUITING · NA
-
Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury
RECRUITING · NA
-
Evaluation of Well-being Interventions in Adults With TBI
RECRUITING · NA
-
Evaluation of Decision-Making Fatigue After Traumatic Brain Injury
RECRUITING · NA
-
Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury
RECRUITING · NA
-
InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI